Showing results (131-140 of 417) with videos related to

Sort By:
Pageof 42
Frontiers in Immunology|May 28, 2019
Corrigendum: Targeting Complement Pathways in Polytrauma- and Sepsis-Induced Multiple-Organ DysfunctionEbru Karasu, Bo Nilsson, Jörg Köhl, et al.
Frontiers in Immunology|April 30, 2019
Complementing the Cancer-Immunity CycleRuben Pio, Daniel Ajona, Sergio Ortiz-Espinosa, et al.
Expert Review of Hematology|September 13, 2014
Complement in paroxysmal nocturnal hemoglobinuria: exploiting our current knowledge to improve the treatment landscapeDimitrios C Mastellos, Daniel Ricklin, Despina Yancopoulou, et al.
Frontiers in Immunology|April 6, 2019
Targeting Complement Pathways in Polytrauma- and Sepsis-Induced Multiple-Organ DysfunctionEbru Karasu, Bo Nilsson, Jörg Köhl, et al.
Proteomics|December 17, 2004
Partial hepatectomy induced liver proteome changes in miceChristoph W Strey, Mike S Winters, Maciej M Markiewski, et al.
The Journal of Surgical Research|July 22, 2008
Complement component C5a mediates hemorrhage-induced intestinal damageSherry D Fleming, Lauren M Phillips, John D Lambris, et al.
The Journal of Clinical Investigation|October 7, 2021
Phase IIa clinical trial of complement C3 inhibitor AMY-101 in adults with periodontal inflammationHatice Hasturk, George Hajishengallis, , et al.
Biopolymers|January 1, 2009
NMR evidence of charge-dependent interaction between various PND V3 and CCR5 N-terminal peptidesPetros A Galanakis, Nikolaos G Kandias, Apostolos K Rizos, et al.
Nature Reviews. Immunology|September 19, 2017
Complement in cancer: untangling an intricate relationshipEdimara S Reis, Dimitrios C Mastellos, Daniel Ricklin, et al.
Protein Science : a Publication of the Protein Society|August 9, 2008
Electrostatic contributions drive the interaction between Staphylococcus aureus protein Efb-C and its complement target C3dNurit Haspel, Daniel Ricklin, Brian V Geisbrecht, et al.
Pageof 42